Log in to save to my catalogue

Tanshinone IIA suppresses the progression of lung adenocarcinoma through regulating CCNA2-CDK2 compl...

Tanshinone IIA suppresses the progression of lung adenocarcinoma through regulating CCNA2-CDK2 compl...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_496c6c3dc2a645c2b64d851d115c90dd

Tanshinone IIA suppresses the progression of lung adenocarcinoma through regulating CCNA2-CDK2 complex and AURKA/PLK1 pathway

About this item

Full title

Tanshinone IIA suppresses the progression of lung adenocarcinoma through regulating CCNA2-CDK2 complex and AURKA/PLK1 pathway

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2021-12, Vol.11 (1), p.23681-23681, Article 23681

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Lung adenocarcinoma (LUAD) belongs to a subgroup of non-small cell lung cancer (NSCLC) with an increasing incidence all over the world. Tanshinone IIA (TSA), an active compound of Salvia miltiorrhiza Bunge., has been found to have anti-tumor effects on many tumors, but its anti-LUAD effect and its mechanism have not been reported yet. In this study...

Alternative Titles

Full title

Tanshinone IIA suppresses the progression of lung adenocarcinoma through regulating CCNA2-CDK2 complex and AURKA/PLK1 pathway

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_496c6c3dc2a645c2b64d851d115c90dd

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_496c6c3dc2a645c2b64d851d115c90dd

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-021-03166-2

How to access this item